Topical Peptides in Cosmetic Research: GHK-Cu, Argireline, Matrixyl and Delivery

A topical peptide has to cross the stratum corneum before anything else about it matters, and that single constraint — roughly 500 Da for passive diffusion through intact skin — explains why cosmetic research peptides are overwhelmingly tri-, tetra- and pentapeptides rather than the larger sequences used in injectable work. Topical peptides are formulated as aqueous serums, emulsified creams and alcohol-based scalp solutions, and each vehicle changes how much peptide reaches the viable epidermis. This guide covers the barrier, the four peptide classes used in cosmetic research, how loading percentages translate into concentration, and what the published evidence does and does not support. It describes laboratory and cosmetic research preparations.

The barrier and the 500-dalton rule

The stratum corneum is 10–20 µm of anucleate corneocytes embedded in a lamellar lipid matrix of ceramides, cholesterol and free fatty acids. Passive permeation runs mainly through that lipid phase, which favours small, moderately lipophilic molecules. The widely cited "500 Dalton rule" — proposed from analysis of topically active drugs and contact allergens — holds that molecules above roughly 500 Da rarely permeate intact skin in useful amounts.

Peptides are hydrophilic and often charged, so they are doubly disadvantaged. Three routes are used to get around this:

• Stay small. GHK-Cu is a tripeptide-copper complex at 403.93 Da, comfortably under the ceiling.
• Add a lipid tail. Palmitoylation attaches a 16-carbon fatty acid to the N-terminus, raising the partition coefficient so the peptide dissolves into the lipid lamellae. Palmitoyl pentapeptide-4 (Matrixyl, 802.05 Da) exceeds 500 Da yet permeates measurably because of that tail.
• Change the vehicle. Ethanol, propylene glycol, glycerol and certain surfactants fluidise the lipid matrix; occlusion under an emulsion raises corneocyte hydration and swells the intercellular route.

Four classes of topical peptides in cosmetic research

Note that the two neurotransmitter-inhibitor peptides sit above the 500 Da line and carry no lipid tail. Their permeation in published studies is modest, and this is the most contested part of the cosmetic peptide literature: an in-vitro SNARE-competition result establishes a mechanism in a dish, not delivery to a neuromuscular junction through intact skin.

What the evidence actually supports

GHK-Cu has the deepest record — Loren Pickart's group first isolated it from human plasma in the early 1970s, and subsequent work reported effects on collagen, glycosaminoglycan and decorin synthesis in fibroblast culture and in wound models, with several small human split-face studies on skin appearance. The background is covered in what is GHK-Cu. Matrixyl's evidence is mostly manufacturer-run and fibroblast-based with a small number of controlled human studies. Argireline's is dominated by in-vitro mechanism work plus vendor-sponsored clinical studies with small cohorts. In every case the honest framing is "reported in", not "shown to", and none of these are treatments for any condition.

Worked example: loading, concentration and molarity

Cosmetic labels quote percentages, research protocols want molarity, and the two are trivially convertible once you fix the units.

1. Percent to mg/mL. 1% w/v = 1 g per 100 mL = 10 mg/mL. So 0.05% w/v = 0.5 mg/mL = 500 µg/mL = 500 ppm.
2. Building a 30 mL serum at 0.05% GHK-Cu. 30 mL × 0.5 mg/mL = 15 mg of peptide. A 50 mg research vial makes three such bottles with material to spare.
3. Percent to molarity. 0.5 mg/mL is 0.5 g/L; divide by the molecular weight 403.93 g/mol → 1.24 mM. Fibroblast studies commonly work in the 1–100 µM range, so a 0.05% topical serum is roughly 10–1,000 times the concentration used in culture — before any barrier losses.
4. Reading a "10%" label. A serum described as Argireline 10% almost always means 10% of a supplied concentrate, and that concentrate is itself typically 5% peptide in solution. Actual acetyl hexapeptide-8 content is therefore near 0.5% w/v, not 10%. Ask for the peptide content in mg/mL if the number matters to your design.

That last point is the single most common misreading in the category, and it is worth writing into any protocol that compares products.

Vehicle: serum, cream or solution

• Aqueous serums — such as the GHK-Cu face serum and Matrixyl serum — keep hydrophilic peptides in their preferred phase, dry quickly, and give the shortest contact time. Best where the peptide is small and water-soluble.
• Emulsified creams such as the GHK-Cu cream add occlusion, which raises corneocyte hydration and extends contact. The trade-off is a more complex matrix with more opportunity for the peptide to partition into the oil phase and never reach skin.
• Alcohol- or glycol-based solutions such as the GHK-Cu hair and scalp solution spread over hair-bearing skin and exploit the follicular route, which bypasses the stratum corneum entirely and is disproportionately important for hair research.
• Combination formulations such as the GHK-Cu + SNAP-8 serum pair a permeating carrier peptide with a larger one; interpret results as the formulation's, not either peptide's.

Formulation chemistry that breaks peptides

• pH. GHK-Cu's copper coordination is pH-dependent and the complex is most stable near neutral; strongly acidic vehicles (a 3.5 pH vitamin C serum, for example) will strip copper and change the molecule.
• Chelators. EDTA is a routine cosmetic preservative-booster and a copper chelator. It does not belong in a copper-peptide formulation.
• Strong oxidisers and reducers. Methionine, cysteine and tryptophan residues oxidise readily; combining copper peptides with high-percentage ascorbic acid or with retinoids in one layer is a chemistry problem, not a routine.
• Preservation. Water-containing formulations need a preservative system. An unpreserved handmade serum has a working life of days refrigerated, and microbial growth is the usual failure mode long before the peptide degrades.

Common mistakes

• Reading concentrate percentage as peptide percentage. The two differ by roughly an order of magnitude.
• Assuming a large peptide permeates because a small one does. The 500 Da line is a real discontinuity, and a lipid tail — not wishful formulation — is what moves a molecule across it.
• Formulating a copper peptide with EDTA or at low pH.
• Citing fibroblast-culture results as skin outcomes. Concentration in a dish and concentration in viable epidermis after barrier loss are different quantities.

The full range sits in the topical peptide creams and serums collection.

Reading the finished range by stated concentration

Only some of the finished topicals state an active concentration, and only those can be compared with each other on the axis that matters. Four do. GHK-Cu Cream is 1% w/w, approximately 10 milligrams of the complex per gram. GHK-Cu Hair & Scalp Solution is 1% w/v, 10 milligrams per millilitre. BPC-157 Cream is 500 micrograms per gram, which is 0.05% w/w. BPC-157 + TB-500 Cream carries 500 micrograms per gram of each peptide, 1 milligram per gram in total.

Convert those to total content and the design intent becomes visible. A 30 gram jar of the copper cream holds roughly 300 milligrams of GHK-Cu; a 30 gram jar of BPC-157 Cream holds about 15 milligrams, and the 50 gram jar about 25. Twenty times the loading per gram, and the reason is the barrier rather than relative potency: GHK-Cu at 403.93 Da is under the 500 Dalton line, while BPC-157 at 1,419.55 Da is nearly three times over it and carries no lipid tail. A 0.05% loading of a large hydrophilic peptide in an emollient base is a penetration-study article, which is precisely how its specification describes it — percutaneous penetration of large hydrophilic peptides, vehicle and occlusion effects, and ex-vivo skin models. Reading it as a delivery format rather than as the experiment it is set up to be is the mistake to avoid.

The rest of the finished range states no concentration on the listing. GHK-Cu + Niacinamide Cream, GHK-Cu + AHK-Cu Hair Serum, Glutathione Brightening Cream, Methylene Blue Face Cream and Lemon Bottle Lipolysis Solution all leave the figure to the lot label, and in the methylene blue case the specification describes the level qualitatively, as a sub-staining tint-free amount with the number printed per lot. That is a defensible way to specify a dye and an awkward one for a research protocol. A product named for its active with no number attached cannot be placed on the same axis as one stating 10 milligrams per gram, so for any cross-product comparison the question to ask is simply milligrams per gram or per millilitre. Two listings put a number in the product name instead — Argireline Serum 10% and Matrixyl Serum 3000 — and neither of those figures is a peptide concentration, for the reason worked through above.

The copper topicals are their own category

Six of the finished topicals are built on a copper complex: GHK-Cu Face Serum, GHK-Cu Cream, GHK-Cu + Niacinamide Cream, GHK-Cu + SNAP-8 Serum, GHK-Cu Hair & Scalp Solution and GHK-Cu + AHK-Cu Hair Serum. All are blue, in the jar and on the skin, and the colour is the coordination indicator rather than a cosmetic choice — if a copper formulation is not blue, the copper is not where the label says it is. The pH and chelator cautions above apply to every one of them.

Two of the six deserve a specific note. Niacinamide is a pyridine carboxamide and a weak metal ligand in its own right, so a copper-peptide and niacinamide cream raises a coordination question alongside the usual formulation ones; the thing to ask for is stability data on the pair rather than on each component separately. And the hair-directed pair exploit the follicular route, which matters because AHK-Cu is GHK-Cu with alanine in place of glycine at 417.96 g/mol as the copper complex — a one-residue difference that the GHK-Cu versus AHK-Cu comparison works through, and the reason a serum containing both is a formulation rather than a head-to-head.

Three articles filed with the topicals that are not peptides

Methylene Blue Face Cream carries a phenothiazinium dye of 319.85 g/mol — small, redox-active and not a peptide at all, so none of the peptide-stability reasoning applies to it and the relevant questions are photostability and staining threshold. PDRN is polydeoxyribonucleotide from salmon DNA, supplied as a 2% aqueous solution; like hyaluronic acid it is polydisperse, so there is no single molecular weight and the lot certificate specifies a chain-length distribution instead of a mass. And Lemon Bottle Lipolysis Solution is supplied in sealed 10 mL vials rather than as a leave-on product, which makes it a vialled solution filed with the topicals by category rather than by format.

Glutathione Brightening Cream sits on the boundary and is worth one line of its own. Glutathione is genuinely a tripeptide, gamma-Glu-Cys-Gly at 307.32 g/mol, but a non-ribosomal one joined through a gamma-carboxyl rather than the usual alpha linkage, and its cysteine thiol oxidises on air exposure faster than almost anything else in the range. An opaque jar kept closed is the right container for it; an unstated concentration is the wrong documentation.

The powders behind the serums

Most of the cosmetic actives are stocked as raw material as well as in finished form, and the powder is what to buy when the vehicle is the variable rather than the peptide. The signal-peptide range includes Argireline, SNAP-8, Matrixyl, Pentapeptide-18, Vialox, Syn-AKE, Syn-Coll, Palmitoyl Tetrapeptide-7, Tripeptide-29, Nonapeptide-1, Pal-AHK, GHK Basic and Decapeptide-12, which maps onto the four classes above rather than onto the finished shelf. Two of those need a word on nomenclature, because trade names hide the chemistry. GHK Basic is Tripeptide-1, the copper-free Gly-His-Lys sequence — it is not GHK-Cu, it will not give a blue solution, and substituting one for the other changes the molecule rather than the formulation. Tripeptide-29 is Gly-Pro-Hyp, a collagen-derived sequence rather than a signal peptide in the Argireline sense. Building from powder also puts the concentration under your control, which is the only way to treat the percent-to-molarity arithmetic above as a designed variable instead of reading it off someone else's label.

Frequently Asked Questions

Related Guides

Using ELISA/RIA Kits in Peptide Research: Standards, Range and Sensitivity

Most peptides are too small for a sandwich ELISA, so signal falls as concentration rises. Here is how to build the standard curve, validate the result and avoid inverting the conclusion.

What is 5-Amino-1MQ? Structure, Mechanism and Research Overview

5-Amino-1MQ is a small-molecule NNMT inhibitor studied for adipocyte NAD+ and methyl-donor metabolism. Structure, reported mechanism and what the evidence covers.